These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 242202

  • 1. The possible involvement of GABA mechanisms in the action of benzodiazepines on central catecholamine neurons.
    Fuxe K, Agnati LF, Bolme P, Hökfelt T, Lidbrink P, Ljungdahl A, Pérez de la Mora M, Ogren S.
    Adv Biochem Psychopharmacol; 1975; (14):45-61. PubMed ID: 242202
    [Abstract] [Full Text] [Related]

  • 2. The possible involvement of GABA mechanisms in the action of benzodiazepines on central catecholamine neurons.
    Fuxe K, Agnati L, Bolme P.
    Psychopharmacol Bull; 1975 Oct; 11(4):55-6. PubMed ID: 719
    [No Abstract] [Full Text] [Related]

  • 3. Possible involvement of GABA in the central actions of benzodiazepines.
    Haefely W, Kulcsár A, Möhler H, Pieri L, Polc P, Schaffner R.
    Adv Biochem Psychopharmacol; 1975 Oct; (14):131-51. PubMed ID: 242199
    [Abstract] [Full Text] [Related]

  • 4. Effects of acute central and peripheral administration of nicotine on ascending dopamine pathways in the male rat brain. Evidence for nicotine induced increases of dopamine turnover in various telencephalic dopamine nerve terminal systems.
    Andersson K, Fuxe K, Agnati LF, Eneroth P.
    Med Biol; 1981 Jun; 59(3):170-6. PubMed ID: 6458747
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evidence for an inhibitory gabergic control of the meso-limbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs.
    Fuxe K, Hökfelt T, Ljungdahl A, Agnati L, Johansson O, Perez de la Mora M.
    Med Biol; 1975 Jun; 53(3):177-83. PubMed ID: 1160412
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Possible involvement of GABA mechanisms in central cardiovascular and respiratory control. Studies on the interaction between diazepam, picrotoxin and clonidine.
    Bolme P, Fuxe K.
    Med Biol; 1977 Dec; 55(6):301-9. PubMed ID: 599969
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential involvement of ventral tegmental GABA(A) and GABA(B) receptors in the regulation of the nucleus accumbens dopamine response to stress.
    Doherty M, Gratton A.
    Brain Res; 2007 May 30; 1150():62-8. PubMed ID: 17395162
    [Abstract] [Full Text] [Related]

  • 12. Effects of benzodiazepines on central serotonergic mechanisms.
    Stein L, Wise CD, Belluzzi JD.
    Adv Biochem Psychopharmacol; 1975 May 30; (14):29-44. PubMed ID: 242201
    [Abstract] [Full Text] [Related]

  • 13. Evidence for involvement of GABA in the action of benzodiazepines: studies on rat cerebellum.
    Costa E, Guidotti A, Mao CC.
    Adv Biochem Psychopharmacol; 1975 May 30; (14):113-30. PubMed ID: 242198
    [No Abstract] [Full Text] [Related]

  • 14. The turnover rate of gamma-aminobutyric acid in the nuclei of telencephalon: implications in the pharmacology of antipsychotics and of a minor tranquilizer.
    Mao CC, Marco E, Revuelta A, Bertilsson L, Costa E.
    Biol Psychiatry; 1977 Jun 30; 12(3):359-71. PubMed ID: 17436
    [Abstract] [Full Text] [Related]

  • 15. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
    Popik P, Kostakis E, Krawczyk M, Nowak G, Szewczyk B, Krieter P, Chen Z, Russek SJ, Gibbs TT, Farb DH, Skolnick P, Lippa AS, Basile AS.
    J Pharmacol Exp Ther; 2006 Dec 30; 319(3):1244-52. PubMed ID: 16971504
    [Abstract] [Full Text] [Related]

  • 16. Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors.
    Fuxe K, Fredholm BB, Agnati LF, Corrodi H.
    Brain Res; 1978 May 12; 146(2):295-311. PubMed ID: 647392
    [Abstract] [Full Text] [Related]

  • 17. Effects of chronic treatment with 1-sulpiride and haloperidol on central dopamine turnover evaluated in dopamine cell body and nerve terminal-rich areas.
    Agnati LF, Andersson K, Fuxe K, Benfenati F, Cortelli P, D'Alessandro R, Ogren SO.
    Adv Biochem Psychopharmacol; 1980 May 12; 24():75-80. PubMed ID: 7405679
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of anticonvulsant drug action.
    Macdonald RL, McLean MJ.
    Electroencephalogr Clin Neurophysiol Suppl; 1987 May 12; 39():200-8. PubMed ID: 2888643
    [Abstract] [Full Text] [Related]

  • 19. Electrophysiological actions of benzodiazepines.
    Geller HM, Hoffer BJ, Taylor DA.
    Fed Proc; 1980 Oct 12; 39(12):3016-23. PubMed ID: 6252064
    [Abstract] [Full Text] [Related]

  • 20. Behavioral analysis of the effects and mechanisms of action of benzodiazepines.
    Cook L, Sepinwall J.
    Adv Biochem Psychopharmacol; 1975 Oct 12; (14):1-28. PubMed ID: 242196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.